NMRA Q1 2026 Earnings NarrowerThanExpected Loss and Steady Progress in CNS Pipeline RDZN Q1 2026 Earnings Significant EPS Miss Raises Concerns NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Margins Face Pressure VEEV Q1 2026 Earnings EPS Surprises with 448 Beat Amid Modest Market Reaction NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances PED Q1 2026 Earnings Strong EPS Beat Highlights Operational Progress